These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet effect of aspirin in patients with coronary artery disease. Grove EL Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204 [TBL] [Abstract][Full Text] [Related]
5. Towards a definition of aspirin resistance: a typological approach. Weber AA; Przytulski B; Schanz A; Hohlfeld T; Schrör K Platelets; 2002 Feb; 13(1):37-40. PubMed ID: 11918835 [TBL] [Abstract][Full Text] [Related]
6. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy]. Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259 [TBL] [Abstract][Full Text] [Related]
7. Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans. Anger K; Kempfert J; Kostelka M; Mohr FW; Dhein S Pharmacology; 2010; 85(4):241-7. PubMed ID: 20332671 [TBL] [Abstract][Full Text] [Related]
8. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358 [TBL] [Abstract][Full Text] [Related]
9. Screening for aspirin resistance in stable coronary artery patients by three different tests. Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552 [TBL] [Abstract][Full Text] [Related]
10. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related]
11. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils. González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353 [TBL] [Abstract][Full Text] [Related]
12. Factors responsible for "aspirin resistance" - can we identify them? Postuła M; Tarchalska-Kryńska B; Filipiak KJ; Kosior D; Serafin A; Huczek Z; Opolski G Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation. Patrick J; Dillaha L; Armas D; Sessa WC Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572 [TBL] [Abstract][Full Text] [Related]
14. Resistance to acetylsalicylic acid in patients after ischemic stroke. Zytkiewicz M; Giełwanowska L; Wojtasińska E; Psuja P; Zawilska K Pol Arch Med Wewn; 2008 Dec; 118(12):727-33. PubMed ID: 19202951 [TBL] [Abstract][Full Text] [Related]
15. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays. Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823 [TBL] [Abstract][Full Text] [Related]
16. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678 [TBL] [Abstract][Full Text] [Related]
17. Aspirin resistance: is this term meaningful? Violi F; Pignatelli P Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437 [TBL] [Abstract][Full Text] [Related]
18. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375 [TBL] [Abstract][Full Text] [Related]
19. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. Watala C; Pluta J; Golanski J; Rozalski M; Czyz M; Trojanowski Z; Drzewoski J J Mol Med (Berl); 2005 Feb; 83(2):148-58. PubMed ID: 15723265 [TBL] [Abstract][Full Text] [Related]
20. Variable platelet response to aspirin in patients with ischemic stroke. Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]